Atara Biotherapeutics Posts Quarterly Earnings Results, Beats Estimates By 0.84 EPS

ATRA Stock  USD 10.35  0.16  1.52%   
About 67% of Atara Biotherapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Atara Biotherapeutics suggests that many traders are alarmed. The current market sentiment, together with Atara Biotherapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Atara Biotherapeutics stock news signals to limit their universe of possible portfolio assets.
  
Atara Biotherapeutics issued its quarterly earnings data on Tuesday. The biotechnology company reported earnings per share for the quarter, beating analysts consensus estimates of by 0.84, Zacks reports. The business had revenue of 40.19 million during the quarter, compared to the consensus estimate of 23.00 million. During

Read at thelincolnianonline.com
news
  

Atara Biotherapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Atara Biotherapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Atara Biotherapeutics Fundamental Analysis

We analyze Atara Biotherapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atara Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atara Biotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Asset

Current Asset Comparative Analysis

Atara Biotherapeutics is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Atara Biotherapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Atara Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Atara Biotherapeutics could also be used in its relative valuation, which is a method of valuing Atara Biotherapeutics by comparing valuation metrics with similar companies.

Peers

Atara Biotherapeutics Related Equities

XFORX4 Pharmaceuticals   13.85   
0%
100.0%
CRBUCaribou Biosciences   1.57   
0%
11.0%
APLSApellis Pharmaceuticals   1.42   
0%
10.0%
ALLOAllogene Therapeutics   0.49   
0%
3.0%
ITOSIteos Therapeutics   1.03   
7.0%
0%
TCRXTscan Therapeutics   1.33   
9.0%
0%
MREOMereo BioPharma   1.45   
10.0%
0%
HRTXHeron Therapeuti   1.79   
12.0%
0%
HOOKHookipa Pharma   1.84   
13.0%
0%
SANASana Biotechnology   2.55   
18.0%
0%
RCUSArcus Biosciences   2.60   
18.0%
0%
ABOSAcumen Pharmaceuticals   2.96   
21.0%
0%
KPTIKaryopharm Therapeutics   4.29   
30.0%
0%
BTAIBioXcel Therapeutics   4.88   
35.0%
0%
FATEFate Therapeutics   6.00   
43.0%
0%

Complementary Tools for Atara Stock analysis

When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Share Portfolio
Track or share privately all of your investments from the convenience of any device